Levy Richard S
SEC insider (Form 3/4/5 filer). CIK 0001454983. Director at Kiniksa Pharmaceuticals International, plc (KNSA) and 3 other issuers. 59 reported Form 4/5 transactions since Sep 2024; latest on Aug 1, 2026. Located in LONDON.
Companies Levy Richard S has filed insider reports for
- Kiniksa Pharmaceuticals International, plc (KNSA): Director
- Kodiak Sciences Inc. (KOD): Director
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Director
- Protara Therapeutics, Inc. (TARA): Director
Levy Richard S
CIK: 0001454983
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (59 total)
- Aug 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
403 shares- - Aug 1, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect403 shares- - Jun 30, 2026KOD
Kodiak Sciences Inc.
AwardDirectStock Option (Right to Buy)
17.7K shares- - Jun 17, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
AwardDirect454 shares- - Jun 15, 2026TARA
Protara Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
31K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectShare Option
12.2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
AwardDirectRestricted Share Units
2K shares- - May 29, 2026KNSA
Kiniksa Pharmaceuticals International, plc
ExerciseDirect2.8K shares- - May 22, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect40 shares at avg. $506.68$20K - May 22, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
SaleDirect439 shares at avg. $512.50$225K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 1, 2026 |  KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 403 | - | - | Direct |
| Aug 1, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 403 | - | $0 | Direct |
| Jun 30, 2026 |  KOD Kodiak Sciences Inc. | Award Stock Option (Right to Buy) | 17,731 | - | - | Direct |
| Jun 17, 2026 |  MDGL MADRIGAL PHARMACEUTICALS, INC. | Award | 454 | - | $0 | Direct |
| Jun 15, 2026 |  TARA Protara Therapeutics, Inc. | Award Stock Option (Right to Buy) | 31,000 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Share Option | 12,158 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Award Restricted Share Units | 2,026 | - | - | Direct |
| May 29, 2026 | KNSA Kiniksa Pharmaceuticals International, plc | Exercise | 2,799 | - | $0 | Direct |
| May 22, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 40 | $506.68 | $20,267 | Direct |
| May 22, 2026 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale | 439 | $512.50 | $224,988 | Direct |
1-10 of 59 transactions